Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement

Support Care Cancer. 2011 Mar:19 Suppl 1:S1-4. doi: 10.1007/s00520-010-0920-z. Epub 2010 May 26.

Abstract

This paper will evaluate various topics related to chemotherapy-induced nausea and vomiting. The results published reflect a consensus conference convened in Perugia, Italy. The topics discussed include antiemetic therapy of multiple-day chemotherapy, high-dose chemotherapy, and rescue antiemetics.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Antiemetics / administration & dosage*
  • Antiemetics / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Dexamethasone / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Nausea / chemically induced
  • Nausea / drug therapy
  • Nausea / prevention & control*
  • Serotonin 5-HT3 Receptor Antagonists / therapeutic use
  • Stem Cell Transplantation / adverse effects
  • Vomiting / chemically induced
  • Vomiting / drug therapy
  • Vomiting / prevention & control*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Serotonin 5-HT3 Receptor Antagonists
  • Dexamethasone